Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2021   64,324,628      
Beginning balance at Dec. 31, 2021 $ 112,301 $ 0 $ 294,230 $ (181,898) $ (31)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares)   1,069,935      
Issuance of common shares from stock option exercises 1,315   1,315    
Issuance of common shares from the employee stock purchase plan (in shares)   165,347      
Issuance of common shares from the employee stock purchase plan 858   858    
Offering costs (271)   (271)    
Vesting of restricted stock units (in shares)   179,143      
Stock-based compensation 18,752   18,752    
Foreign currency translation adjustments, net of tax (10)       (10)
Net unrealized gain on investments 12       12
Net loss (49,738)     (49,738)  
Ending balance (in shares) at Dec. 31, 2022   65,739,053      
Ending balance at Dec. 31, 2022 83,219 $ 0 314,884 (231,636) (29)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares)   1,756,386      
Issuance of common shares from stock option exercises 12,866   12,866    
Issuance of common shares from the employee stock purchase plan (in shares)   292,246      
Issuance of common shares from the employee stock purchase plan 1,329   1,329    
Vesting of restricted stock units (in shares)   3,662,161      
Common stock withheld related to net settlement of equity awards (in shares)   (1,333,489)      
Common stock withheld related to net settlement of equity awards (10,388)   (10,388)    
Stock-based compensation 22,823   22,823    
Foreign currency translation adjustments, net of tax 108       108
Net unrealized gain on investments 31       31
Net loss $ (31,031)     (31,031)  
Ending balance (in shares) at Dec. 31, 2023 70,116,357 70,116,357      
Ending balance at Dec. 31, 2023 $ 78,957 $ 0 341,514 (262,667) 110
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares) 325,641 325,641      
Issuance of common shares from stock option exercises $ 1,727   1,727    
Issuance of common shares from the employee stock purchase plan (in shares)   220,042      
Issuance of common shares from the employee stock purchase plan $ 1,997   1,997    
Vesting of restricted stock units (in shares)   4,198,162      
Common stock withheld related to net settlement of equity awards (in shares) (1,634,949) (1,634,949)      
Common stock withheld related to net settlement of equity awards $ (18,855)   (18,855)    
Stock-based compensation 32,166   32,166    
Foreign currency translation adjustments, net of tax (657)       (657)
Net unrealized gain on investments (21)       (21)
Net loss $ (28,346)     (28,346)  
Ending balance (in shares) at Dec. 31, 2024 73,225,253 73,225,253      
Ending balance at Dec. 31, 2024 $ 66,968 $ 0 $ 358,549 $ (291,013) $ (568)